Colgate-Palmolive (India) Limited (500830) fair value: what the stock is really worth
We calculate from audited financials what Colgate-Palmolive (India) Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Watch Colgate-Palmolive (India) Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 19, 2026.
How to read this chart
60‑month range ₹1,259 – ₹3,685 · fair‑value band ₹610.09 – ₹1,111 · the ₹1,885 price screens above the ₹835.22 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 19, 2026.
Colgate-Palmolive (India) Limited (500830) currently trades at ₹1,885, while our model-based Fair Value estimate is ₹835.22, implying the stock looks roughly 125.7% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹1,101 per share, and 0 of the 23 models we run sit above the ₹1,885 price.
Bear case: the Multiples group reads lowest at ₹420.90, and 23 of the 23 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹610.09 (bear) to ₹1,111 (bull), the price of ₹1,885 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 82/100 (high quality), in the Consumer Staples sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Colgate-Palmolive (India) Limited reported revenue of ₹59.8B in FY2025 versus ₹51.0B in FY2021, a compound +4.1%/yr. Reported net income was ₹13.3B in FY2025, compounding +5.3%/yr from FY2021.
Key figures
Market cap ₹513B (≈ $5.3B) · P/E ratio 45.0 · P/S ratio 9.96 · EPS (TTM) ₹38.07 · Dividend yield 3.0% · Net margin 22.1% · Return on equity 7,503% · Return on assets (EBIT) 51.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 23% below its 52-week high and 7% above its 52-week low.
For context, the median of 10 Consumer Staples peers we cover trades at −34% fair-value upside, at −56%, 500830 screens richer than that median.
Fair Value models
Bear ₹610.09Fair Value ₹835.22Bull ₹1,111
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (₹27.64 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.66/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−0.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.3%
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+8.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.1%
Dividend (yield on the price)3.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5% vs 9%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.28% → 29%
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+23.2%
Yearly growth needed for the next five years to justify today's price.
Compare Colgate-Palmolive (India) Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Personal Products” was too small, so the broader sector is used.)Consumer Staples · 1785 stocks
Beats the sector median on 4/10 measures
A mixed picture versus its sector peers.
Valuation
Quality Score82 · Top 25%
Fair Value upside−55% · Bottom 25%
Profitability
Return on assets0% · Bottom 25%
Net margin (TTM)0% · Bottom 25%
Operating margin (TTM)0% · Bottom 25%
Growth and dividend
Revenue growth0% · Below median
Dividend yield (TTM)3.0% · Above median
Valuation Multiplesvs Consumer Staples median · lower = cheaper
P/E (TTM)45.0× · Priciest 25%
P/B0.31× · Cheapest 25%
P/FCF0.3× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 29
FUTURE (revenue growth)0· sector 15
PAST (return on equity)0· sector 26
HEALTH (low debt)100· sector 96
DIVIDEND (yield)60· sector 56
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Colgate-Palmolive (India) Limited (500830) overvalued or undervalued?
As of Sep 19, 2026, our model estimates a fair value of ₹835.22 versus a price of ₹1,885, about −56% upside (overvalued).
What is the fair value of 500830?
Our model-based fair value for Colgate-Palmolive (India) Limited is ₹835.22 (as of Sep 19, 2026), built from audited fundamentals. The current price: ₹1,885.
What is the quality score of 500830?
Colgate-Palmolive (India) Limited has a Quality Score of 82/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Colgate-Palmolive (India) Limited (500830)?
Our model-based price target is the fair value of ₹835.22 (as of Sep 19, 2026) from 23 valuation models. Cautious scenario ₹610.09, optimistic scenario ₹1,111. It is a calculation from audited fundamentals, not an analyst target.
What is the Colgate-Palmolive (India) Limited stock forecast for 2026?
Our models put fair value at ₹835.22, about −56% upside versus a price of ₹1,885 (overvalued). Cautious scenario ₹610.09, optimistic scenario ₹1,111. The calculation is refreshed regularly with new filings.
Does Colgate-Palmolive (India) Limited pay a dividend?
Colgate-Palmolive (India) Limited currently shows a dividend yield of about 2.98% relative to its recent price (as of Sep 19, 2026).
What growth is priced into Colgate-Palmolive (India) Limited (500830)?
For today's price to be fair in a discounted-cash-flow model, Colgate-Palmolive (India) Limited would have to grow free cash flow by +23.2 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.3 % per year. As of Sep 19, 2026.
What discount rate (WACC) does the fair value of 500830 use?
Our models discount Colgate-Palmolive (India) Limited at 12.4 %: a base by market capitalisation (mid), country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Colgate-Palmolive (India) Limited that is +23.2 % per year a year over ten years, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Colgate-Palmolive (India) Limited (500830) delivered so far?
Over the past 5 years revenue at Colgate-Palmolive (India) Limited grew +4.3 % a year. The price currently implies +23.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
What is the free cash flow yield of Colgate-Palmolive (India) Limited (500830)?
The free-cash-flow yield on the price is 3.37 %: that much free cash flow Colgate-Palmolive (India) Limited produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Colgate-Palmolive (India) Limited (500830)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Colgate-Palmolive (India) Limited it is ₹835.22 per share (as of Sep 19, 2026), against a price of ₹1,885. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Colgate-Palmolive (India) Limited stock overvalued or undervalued in 2026?
As of Sep 19, 2026, 500830 trades above its calculated fair value: price ₹1,885, fair value ₹835.22, a gap of about −56% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 500830?
No. The price is what the market pays today (₹1,885); the fair value is what the company's own numbers justify (₹835.22). For Colgate-Palmolive (India) Limited the two are ₹1,050 per share apart. That gap is exactly why we show both numbers side by side.
How much is Colgate-Palmolive (India) Limited worth?
The market values Colgate-Palmolive (India) Limited at about ₹513B (market capitalisation, as of Sep 19, 2026). Per share that is ₹1,885; our models calculate a fair value of ₹835.22 per share.
What do the bullish and bearish scenarios say about 500830?
Our models span a range for Colgate-Palmolive (India) Limited: cautious scenario ₹610.09, base ₹835.22, optimistic ₹1,111 per share (as of Sep 19, 2026, price ₹1,885). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 500830?
Colgate-Palmolive (India) Limited trades at a price-to-earnings ratio of 45.0 (as of Sep 19, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹835.22 is built from several models across several years. Other multiples: P/B 0.3.
How far is 500830 from its 52-week high?
Colgate-Palmolive (India) Limited trades at ₹1,885, about 23% below its 52-week high of ₹2,449 and 7% above the low of ₹1,761 (as of Sep 19, 2026). Distance from the high says nothing about value: that is what the fair value of ₹835.22 is for.
Which stocks are comparable to Colgate-Palmolive (India) Limited?
From the same area (Consumer Staples) we also value Godrej Consumer Products Limited, Marico Limited, Gillette India Limited, Jyothy Labs Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Colgate-Palmolive (India) Limited stock attractive at the current price?
The data as of Sep 19, 2026: price ₹1,885, calculated fair value ₹835.22 (−56%), Quality Score 82/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 500830 calculated?
We run Colgate-Palmolive (India) Limited through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹835.22, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 16.1 % above its aggregate fair value. Colgate-Palmolive (India) Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Colgate-Palmolive (India) Limited (500830)?
The closing price on Sep 18, 2026 was ₹1,885. Our model-based fair value is ₹835.22, about −56% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Colgate-Palmolive (India) Limited right now?
A high-quality business (quality 82/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (₹1,111). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (₹610.09 to ₹1,111) leaves room in how you read the outcome.
Key figures of Colgate-Palmolive (India) Limited
How large is the market capitalisation of Colgate-Palmolive (India) Limited (500830)?
The market capitalisation of Colgate-Palmolive (India) Limited is ₹513B (≈ $5.3B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Colgate-Palmolive (India) Limited (500830)?
The price-to-sales ratio of Colgate-Palmolive (India) Limited is 9.96 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Colgate-Palmolive (India) Limited (500830)?
Earnings per share at Colgate-Palmolive (India) Limited are ₹38.07 (price ÷ EPS = P/E 45.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Colgate-Palmolive (India) Limited (500830)?
The dividend yield of Colgate-Palmolive (India) Limited is 3.0% (payout 147%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Colgate-Palmolive (India) Limited (500830)?
The net margin of Colgate-Palmolive (India) Limited is 22.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Colgate-Palmolive (India) Limited (500830)?
The return on equity (ROE) of Colgate-Palmolive (India) Limited is 7,503% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Colgate-Palmolive (India) Limited (500830)?
On an EBIT basis the return on assets of Colgate-Palmolive (India) Limited is 51.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
Free · no account needed
Watch Colgate-Palmolive (India) Limited in the live analysis
One click puts Colgate-Palmolive (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
